Cancer of Colon Clinical Trial
Official title:
Educational Nursing Intervention on Nutrition Impact Side-effects' Self-care Among Patients With Colorectal Cancer During Chemotherapy: A Research Protocol for a Randomised Controlled Trial
NCT number | NCT04160650 |
Other study ID # | NursEff |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 21, 2019 |
Est. completion date | March 15, 2022 |
Verified date | May 2022 |
Source | University of Turku |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The prevalence of malnutrition is common among patients with colorectal cancer. Chemotherapy induced side effects may impact negatively on nutrition intake thus increase the risk of malnutrition and serious complications for patients. Purpose is to test the effect of empowering education on activation and knowledge level among patients with colorectal cancer during the chemotherapy. Secondary outcomes are quality of life and malnutrition. A two-arm, single center, patient blinded superiority trial with stratified randomization (1:1) and with repeated measures is used to measure the effectiveness of face-to-face education on nutrition intake related chemotherapy induced side-effects' self-care compared to standard care. Eligibility criteria are adult patients diagnosed with colorectal cancer and receiving intra venous chemotherapy treatment. Patients are recruited in one university hospital outpatient clinic in Finland. Experienced oncology nurse delivers the intervention two weeks after the first chemotherapy. Primary outcomes are activation in self-care and knowledge level. Secondary outcomes are quality of life and risk of malnutrition measured at baseline (M0) and after eight (M1) and 16 weeks (M2) after the intervention. The study will provide knowledge of nurse-led educational intervention on self-care among patients with colorectal cancer. The findings will contribute to patient education and self-care, thus better quality of life.
Status | Completed |
Enrollment | 82 |
Est. completion date | March 15, 2022 |
Est. primary completion date | March 15, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - able to speak and understand Finnish - receiving chemotherapy every three weeks in outpatient clinic: oxaliplatin+capecitabine= Xelox; irinotecan + capecitabine = Xeliri; Xelox or Xeliri + Bevacizumab Exclusion Criteria: - weak physical, psychological or cognitive function that prevents participation - not able to understand Finnish |
Country | Name | City | State |
---|---|---|---|
Finland | Helsinki University Hospital | Helsinki |
Lead Sponsor | Collaborator |
---|---|
University of Turku | Helsinki University Central Hospital |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Incidence of interruption, transfer and cancellation of the treatments | Better nutritional status is related to better treatment effect and better well-being, which may lead to better adherence to treatment schedule (Ravasco et al. 2012). Data is collected from patients' records. | From the baseline to 8 and 16 weeks after the intervention | |
Other | Incidence of morbidity | Worse nutritional status is related to greater morbidity (Ravasco et al. 2012). Data is collected from patients' records. | From the baseline to 16 weeks after hte intervention | |
Primary | The rate of knowledge level (Knowledge test of malnutrition, nutrition impact side effects and their self-care, RasOma, Tuominen et al. 2019) | Knowledge is seen as essential for empowerment (Rankinen et al. 2014; Castro et al. 2016). It is assumed that knowledge level is better in the intervention group compared to control group. Knowledge test was developed in the research group, which included an oncologist, a dietitian, oncology nurses and a researcher. The instrument includes 15 items (yes/no, right answer=1 point, wrong answer=0 points). | From the baseline to 8 and 16 weeks after the intervention | |
Primary | The rate of self care activation (Patient Activation Measure PAM, Insignia Health; Hibbard et al. 2004) | Activated individuals have the knowledge, skills and confidence to self-manage their health. PAM shows how ready, willing and able an individual is to manage his or her health and healthcare.It is assumed that patients in the intervention group are more activated to self-care their side effects. The activation score is based on a 0-100 point scale. A change of 3-4 points is associated with the difference between engaging and not engaging in particular behaviors. Activation self care is rated from 1 to 4 (1= low activation level; believing the patient role is important, 2=low activation level; having the confidence and knowledge necessary to take action, 3=moderate activation level; actually taking action to maintain and improve one's health, and 4=high activation level; staying the course even in stressful situations)(InsigniaHealth 2017). | From the baseline to 8 and 16 weeks after the intervention | |
Secondary | The incidence of malnutrition risk (Nutritional Risk Screening NRS2002, Kondrup et al. 2003) | Nutrition consultations have affected positively on patients' food intake and nutritional status (Kiss & Krishnasamy 2014; Tu et al. 2013; Ravasco 2011, 2012). Patients with a total score of =3 are classified as nutritionally at risk. It is assumed that malnutrition risk is lesser in the intervention group compared to control group. | From the baseline to 8 and 16 weeks after hte intervention | |
Secondary | The rate of quality of life (The Functional Assessment of Cancer Therapy Scale - Colorectal, FACT-C, Cella et al. 1993) | The risk of malnutrition is strongly associated with QoL in cancer patients initiating chemotherapy (Calderon et al. 2018).The FACT-C questionnaire consists of 36 items on a 5-point Likert scale in four areas of well-being: physical (0-28 points), social (0-28 points), emotional (0-24 points), functional (0-28 points) and CRC subscale (0-28 points). Higher score means better QoL (34 points=low level, 34-68 points= satisfactory, 68-102 points=average and 102-136 points=high)(Ganesh et al. 2016; Gozdziewicz et al. 2017). | From the baseline to 8 and 16 weeks after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06454071 -
Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients
|
Phase 2 | |
Recruiting |
NCT05982184 -
Effect of Music Prehabilitation on Preoperative Anxiety Before Surgery
|
N/A | |
Recruiting |
NCT05179824 -
Tempus Priority Study: A Pan-tumor Observational Study
|
||
Completed |
NCT04716010 -
Developing and Evaluating Product Messaging
|
N/A | |
Terminated |
NCT03524820 -
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02458664 -
BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer
|
N/A | |
Completed |
NCT03246438 -
Choice Architecture and Colorectal Cancer Screening Outreach
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Completed |
NCT03928678 -
Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial
|
N/A | |
Completed |
NCT03546569 -
Tumor Cells, Tumor DNA and Immunological Response in Colonic Stent Placement
|
||
Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
Completed |
NCT05030090 -
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer
|
N/A | |
Not yet recruiting |
NCT04773626 -
Tumor Deposits in Cancer Colon
|
||
Recruiting |
NCT05887531 -
Abdominopelvic Cancer Prehabilitation
|
N/A | |
Withdrawn |
NCT04274790 -
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
|
||
Completed |
NCT03416777 -
Meat-based Versus Pesco-vegetarian Diet and Colorectal Cancer
|
N/A | |
Completed |
NCT03210129 -
Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients
|
N/A |